TGFB1 and neoplasm: Other studies linked increased tumor-associated TGF-β levels with the impairment of the function of NK cells and CTLs, and NKG2D down-regulation in various malignancies including Hodgkin lymphoma (106), gastric cancer (107) and head and neck squamous cell carcinoma (108, 109).